Smith & Nephew 

$30.53
589
-$0.23-0.75% Friday 20:00

Statistics

Day High
30.81
Day Low
30.49
52W High
38.7
52W Low
28.4
Volume
1,038,600
Avg. Volume
-
Mkt Cap
0
P/E Ratio
21.35
Dividend Yield
2.56%
Dividend
0.78

Upcoming

Dividends

2.56%Dividend Yield
May 26
$0.48
Nov 25
$0.3
May 25
$0.46
Nov 24
$0.29
May 24
$0.46
10Y Growth
2.25%
5Y Growth
0.84%
3Y Growth
1.4%
1Y Growth
2.62%

Earnings

4AugExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
0
0.2
0.39
0.59
Expected EPS
0.46875
Actual EPS
N/A

Financials

7.09%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
5.81BRevenue
412MNet Income

Analyst Ratings

30Average Price Target
The highest estimate is 30.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap121.33B
Stryker Corporation is a direct competitor, offering a similar range of orthopedic and medical devices.
Medtronic
MDT
Mkt Cap100.91B
Medtronic plc specializes in medical technologies, services, and solutions, including those for surgical devices, competing in areas overlapping with Smith & Nephew.
Zimmer Biomet
ZBH
Mkt Cap16.54B
Zimmer Biomet Holdings, Inc. competes in the manufacture of musculoskeletal healthcare products, directly overlapping with Smith & Nephew's product lines.
Johnson & Johnson
JNJ
Mkt Cap564.11B
Johnson & Johnson operates in the medical devices sector through its subsidiary DePuy Synthes, which competes in orthopedics, a key area for Smith & Nephew.
Boston Scientific
BSX
Mkt Cap85.88B
Boston Scientific Corporation competes with Smith & Nephew in the medical devices market, particularly in areas of advanced surgical and wound care products.
Intuitive Surgical
ISRG
Mkt Cap155.16B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, competing with Smith & Nephew's advanced surgical technologies.
Abbott Laboratories
ABT
Mkt Cap152.25B
Abbott Laboratories competes in various healthcare segments, including medical devices that overlap with Smith & Nephew's portfolio.
Baxter International
BAX
Mkt Cap9.91B
Baxter International Inc. provides a broad range of hospital and surgical products, competing in the medical supplies and devices sector.
Globus Medical
GMED
Mkt Cap11.51B
Globus Medical, Inc. is a spine and orthopedics-focused company, directly competing with Smith & Nephew in the orthopedic surgery market.
Edwards Lifesciences
EW
Mkt Cap49.39B
Edwards Lifesciences Corporation specializes in heart and critical care products, competing indirectly in the medical devices market.

About

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Show more...
CEO
Dr. Deepak S. Nath Ph.D.
Employees
17349
Country
United Kingdom
ISIN
US83175M2052

Listings

0 Comments

Share your thoughts

FAQ

What is Smith & Nephew stock price today?
The current price of SNN is $30.53 USD — it has decreased by -0.75% in the past 24 hours. Watch Smith & Nephew stock price performance more closely on the chart.
What is Smith & Nephew stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Smith & Nephew stocks are traded under the ticker SNN.
Is Smith & Nephew stock price growing?
SNN stock has fallen by -1.01% compared to the previous week, the month change is a -3.29% fall, over the last year Smith & Nephew has showed a +6.64% increase.
When is the next Smith & Nephew earnings date?
Smith & Nephew is going to release the next earnings report on August 04, 2026.
What were Smith & Nephew earnings last quarter?
SNN earnings for the last quarter are 0.59 USD per share, whereas the estimation was 0.58 USD resulting in a +2.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Smith & Nephew revenue for the last year?
Smith & Nephew revenue for the last year amounts to 5.81B USD.
What is Smith & Nephew net income for the last year?
SNN net income for the last year is 412M USD.
Does Smith & Nephew pay dividends?
Yes, SNN dividends are paid semi-annual. The last dividend per share was 0.3 USD. As of today, Dividend Yield (FWD)% is 2.56%.
How many employees does Smith & Nephew have?
As of May 26, 2026, the company has 17,349 employees.
In which sector is Smith & Nephew located?
Smith & Nephew operates in the Health & Wellness sector.
When did Smith & Nephew complete a stock split?
The last stock split for Smith & Nephew was on October 15, 2014 with a ratio of 2.5:1.
Where is Smith & Nephew headquartered?
Smith & Nephew is headquartered in Watford, United Kingdom.